Jacobs Levy Equity Management’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-13,951
Closed -$76K 1018
2017
Q1
$76K Sell
13,951
-4,200
-23% -$22.9K ﹤0.01% 876
2016
Q4
$90K Sell
18,151
-12,400
-41% -$55.7K ﹤0.01% 913
2016
Q3
$126K Buy
+30,551
New +$134K ﹤0.01% 953
2014
Q1
Sell
-18,256
Closed -$65K 1009
2013
Q4
$65K Sell
18,256
-1,500
-8% -$5.6K ﹤0.01% 919
2013
Q3
$79K Sell
19,756
-5,505
-22% -$20.7K ﹤0.01% 898
2013
Q2
$90K Buy
+25,261
New +$98.6K ﹤0.01% 937

Other funds holding ULBI

Jacobs Levy Equity Management's ULBI Position: Q2 2017 in Review

Jacobs Levy Equity Management sold out of Ultralife (ULBI) in Q2 2017, closing a stake of 13,951 shares — an estimated $76K sold.

Jacobs Levy Equity Management first reported a position in ULBI in Q2 2013 and held it in 6 quarters. The position peaked at $126K in Q3 2016. 42 funds tracked by Wall St. Rank hold ULBI as of Q2 2017.

  • Jacobs Levy Equity Management reported no remaining Ultralife position as of Q2 2017 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 13,951 Ultralife shares in Q2 2017, an estimated $76K.
  • Jacobs Levy Equity Management first reported a position in Ultralife in Q2 2013 and held it in 6 quarters.
  • Jacobs Levy Equity Management's Ultralife position peaked at $126K in Q3 2016.
  • 42 funds tracked by Wall St. Rank held Ultralife as of Q2 2017.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.